Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 35, Issue 10, Pages 1731-1744
Publisher
Wiley
Online
2020-08-20
DOI
10.1002/mds.28215
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease
- (2020) Irene Sebastianutto et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
- (2020) Yaping Chu et al. BRAIN
- Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease
- (2020) John G. Nutt et al. MOVEMENT DISORDERS
- Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study
- (2019) C. Warren Olanow et al. MOVEMENT DISORDERS
- Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior
- (2019) Antonio de Iure et al. MOVEMENT DISORDERS
- Changes in Dendritic Spine Density and Inhibitory Perisomatic Connectivity onto Medium Spiny Neurons in l-Dopa-Induced Dyskinesia
- (2019) G. Gomez et al. MOLECULAR NEUROBIOLOGY
- Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial
- (2019) Peter A LeWitt et al. LANCET NEUROLOGY
- What, If, and When to Move: Basal Ganglia Circuits and Self-Paced Action Initiation
- (2019) Andreas Klaus et al. Annual Review of Neuroscience
- Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia
- (2019) Shayan Pourmirbabaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Immunomodulatory drugs alleviate l ‐dopa‐induced dyskinesia in a rat model of Parkinson's disease
- (2019) Laura Boi et al. MOVEMENT DISORDERS
- Changing views of the pathophysiology of Parkinsonism
- (2019) Thomas Wichmann MOVEMENT DISORDERS
- Role of striatal ΔFosB in l-Dopa–induced dyskinesias of parkinsonian nonhuman primates
- (2019) Goichi Beck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
- (2019) Sanne K. Meles et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
- (2019) C Warren Olanow et al. LANCET NEUROLOGY
- Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry
- (2018) Dongni Johansson et al. CNS Neuroscience & Therapeutics
- Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression
- (2018) Giada Spigolon et al. JOURNAL OF NEURAL TRANSMISSION
- The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective
- (2018) Manolo Carta et al. JOURNAL OF NEURAL TRANSMISSION
- Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
- (2018) Augusta Pisanu et al. JOURNAL OF NEURAL TRANSMISSION
- On the neuronal circuitry mediating l-DOPA-induced dyskinesia
- (2018) M. Angela Cenci et al. JOURNAL OF NEURAL TRANSMISSION
- Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia
- (2018) Michael B. Ryan et al. Cell Reports
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
- (2018) Regina Katzenschlager et al. LANCET NEUROLOGY
- An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in Primates
- (2018) Delphine Charvin et al. MOVEMENT DISORDERS
- Diametric neural ensemble dynamics in parkinsonian and dyskinetic states
- (2018) Jones G. Parker et al. NATURE
- Models of Parkinson’s disease revisited
- (2018) Thomas Wichmann NATURE
- Dopamine neuron activity before action initiation gates and invigorates future movements
- (2018) Joaquim Alves da Silva et al. NATURE
- Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
- (2018) Stéphane Palfi et al. Human Gene Therapy Clinical Development
- Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
- (2018) Alberto J. Espay et al. ANNALS OF NEUROLOGY
- Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
- (2017) Randall W. Moreadith et al. EUROPEAN POLYMER JOURNAL
- Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification
- (2017) Javier Blesa et al. EXPERIMENTAL NEUROLOGY
- Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson’s disease therapy
- (2017) Cristina Alcacer et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss and remodeling of striatal dendritic spines in Parkinson’s disease: from homeostasis to maladaptive plasticity?
- (2017) Rosa M. Villalba et al. JOURNAL OF NEURAL TRANSMISSION
- Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias
- (2017) Barbara Picconi et al. MOVEMENT DISORDERS
- Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias
- (2017) Jennifer Stanic et al. NEUROBIOLOGY OF DISEASE
- Computational Model of Recurrent Subthalamo-Pallidal Circuit for Generation of Parkinsonian Oscillations
- (2017) Osamu Shouno et al. Frontiers in Neuroanatomy
- Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l -DOPA delivery in the 6-OHDA model of Parkinson's disease
- (2016) Giovanna Mulas et al. EXPERIMENTAL NEUROLOGY
- Dynamic DNA Methylation Regulates Levodopa-Induced Dyskinesia
- (2016) David A. Figge et al. JOURNAL OF NEUROSCIENCE
- Hyperkinetic disorders and loss of synaptic downscaling
- (2016) Paolo Calabresi et al. NATURE NEUROSCIENCE
- Serotonin-to-dopamine transporter ratios in Parkinson disease
- (2016) Andreas-Antonios Roussakis et al. NEUROLOGY
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease
- (2015) Leo Verhagen Metman et al. MOVEMENT DISORDERS
- Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
- (2015) Paolo Calabresi et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients
- (2015) Manuela Mellone et al. Frontiers in Cellular Neuroscience
- Mechanisms of Dopamine D1 Receptor-Mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5
- (2014) T. Fieblinger et al. JOURNAL OF NEUROSCIENCE
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results
- (2014) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- Parkinson's Disease, the Subthalamic Nucleus, Inhibition, and Impulsivity
- (2014) Marjan Jahanshahi et al. MOVEMENT DISORDERS
- Direct and indirect pathways of basal ganglia: a critical reappraisal
- (2014) Paolo Calabresi et al. NATURE NEUROSCIENCE
- The place of dopamine in the cortico-basal ganglia circuit
- (2014) S.N. Haber NEUROSCIENCE
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Concurrent activation of striatal direct and indirect pathways during action initiation
- (2013) Guohong Cui et al. NATURE
- Increased motor cortical facilitation and decreased inhibition in Parkinson disease
- (2013) Z. Ni et al. NEUROLOGY
- Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease
- (2012) Cuiping Chen et al. CLINICAL NEUROPHARMACOLOGY
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease
- (2012) V. Bagetta et al. JOURNAL OF NEUROSCIENCE
- Living on the edge with too many mouths to feed: Why dopamine neurons die
- (2012) J. Paul Bolam et al. MOVEMENT DISORDERS
- Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
- (2012) Eunju Shin et al. NEUROBIOLOGY OF DISEASE
- Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
- (2011) Andrew Lees et al. MOVEMENT DISORDERS
- Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
- (2011) Marios Politis et al. MOVEMENT DISORDERS
- Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease
- (2010) D. Nilsson et al. ACTA NEUROLOGICA SCANDINAVICA
- Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study
- (2010) Fabrizio Stocchi et al. ANNALS OF NEUROLOGY
- Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
- (2010) Daniella Rylander et al. ANNALS OF NEUROLOGY
- Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson’s disease
- (2010) Christopher Kobylecki et al. JOURNAL OF NEUROCHEMISTRY
- Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
- (2010) Piotr Hadaczek et al. MOLECULAR THERAPY
- Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
- (2010) Peter Redgrave et al. NATURE REVIEWS NEUROSCIENCE
- Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias
- (2010) B. Ouattara et al. NEUROSCIENCE
- Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction
- (2009) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
- (2009) B. Jarraya et al. Science Translational Medicine
- Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate
- (2009) Monty A. Silverdale et al. SYNAPSE
- The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses
- (2008) Gina G. Turrigiano CELL
- Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis
- (2008) C. Warren Olanow et al. MOVEMENT DISORDERS
- Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains
- (2008) Yoland Smith et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now